HA
Hansa Biopharma
Siste kurs
32,08 SEK
22.7.2026
Siste
36,00 SEK
+12.22%
Oppside
3 mnd
44,50 SEK
+38.72%
Oppside
HNSA
3 mnd+38,72%2 kursmål
6 mnd+38,72%2 kursmål
1 år+159,51%8 kursmål
Maks+159,51%8 kursmål
DNB CarnegieDanske Bank
HelsevesenBiotechnology
Om selskapet
Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia
Tre måneders konsensus
Konsensus
44,50 SEK
Oppside
+38,72%
Siste kurs32,08 SEK
Innsidehandel for Hansa Biopharma
Ingen innsidehandler for valgt periode.
